NTRB Quote, Financials, Valuation and Earnings

NeuroOne Medical Technologies has a net margin of -211% compared to Nutriband's net margin of -163.76%. Nutriband's return on equity of -69.58% beat NeuroOne Medical Technologies's return on equity of -281.01%.

Nutriband has a consensus price target of $13.00, signalling upside risk potential of 100%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 137.28%. Given that NeuroOne Medical Technologies has higher upside potential than Nutriband, analysts believe NeuroOne Medical Technologies is more attractive than Nutriband.

Nutriband has a beta of 1.185, which suggesting that the stock is 18.545% more volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.671%.

Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

Nutriband quarterly revenues are $645.8K, which are smaller than NeuroOne Medical Technologies quarterly revenues of $1.4M. Nutriband's net income of -$1.4M is higher than NeuroOne Medical Technologies's net income of -$2.3M. Notably, Nutriband's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 32.23x versus 3.16x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical has a net margin of -211% compared to Nutriband's net margin of --. Nutriband's return on equity of -69.58% beat enVVeno Medical's return on equity of --.

Nutriband has a consensus price target of $13.00, signalling upside risk potential of 100%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 246.26%. Given that enVVeno Medical has higher upside potential than Nutriband, analysts believe enVVeno Medical is more attractive than Nutriband.

Nutriband has a beta of 1.185, which suggesting that the stock is 18.545% more volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.726%.

Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

Nutriband quarterly revenues are $645.8K, which are larger than enVVeno Medical quarterly revenues of --. Nutriband's net income of -$1.4M is higher than enVVeno Medical's net income of -$4.5M. Notably, Nutriband's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 32.23x versus 352.17x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies has a net margin of -211% compared to Nutriband's net margin of -787.63%. Nutriband's return on equity of -69.58% beat SINTX Technologies's return on equity of -180.99%.

Nutriband has a consensus price target of $13.00, signalling upside risk potential of 100%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 933.21%. Given that SINTX Technologies has higher upside potential than Nutriband, analysts believe SINTX Technologies is more attractive than Nutriband.

Nutriband has a beta of 1.185, which suggesting that the stock is 18.545% more volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.821, suggesting its less volatile than the S&P 500 by 17.937%.

Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

Nutriband quarterly revenues are $645.8K, which are larger than SINTX Technologies quarterly revenues of $291K. Nutriband's net income of -$1.4M is higher than SINTX Technologies's net income of -$2.3M. Notably, Nutriband's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 32.23x versus 2.60x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Beyond Air has a net margin of -211% compared to Nutriband's net margin of -1215.67%. Nutriband's return on equity of -69.58% beat Beyond Air's return on equity of -225.36%.

Nutriband has a consensus price target of $13.00, signalling upside risk potential of 100%. On the other hand Beyond Air has an analysts' consensus of $2.25 which suggests that it could grow by 1133.55%. Given that Beyond Air has higher upside potential than Nutriband, analysts believe Beyond Air is more attractive than Nutriband.

Nutriband has a beta of 1.185, which suggesting that the stock is 18.545% more volatile than S&P 500. In comparison Beyond Air has a beta of 0.250, suggesting its less volatile than the S&P 500 by 75.019%.

Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.

Nutriband quarterly revenues are $645.8K, which are smaller than Beyond Air quarterly revenues of $1.1M. Nutriband's net income of -$1.4M is higher than Beyond Air's net income of -$13M. Notably, Nutriband's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 32.23x versus 3.29x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.